Founder and CEO, Jim Mullowney is a well-known leader and scientist in the hazardous waste industry and a pioneer in the field of cytotoxic sanitary waste. He has devoted many years to developing the Pharma-Cycle™ Solution, receiving six patents that place the company front and center in the global fight to make cancer therapy safer. Jim successfully advocated for federal and state legislation that mandates control of certain cytotoxic chemotherapy drugs from the time they arrive at the pharmacy all the way through excretion by the patient.
Jim has over 30 years of experience in the hazardous waste industry and is a pioneer in the field of cytotoxic sanitary waste. His early endeavors involved cleaning up polluted industrial sites and operating one of five licensed hazardous waste transfer facilities in New England.
When Jim began his career, it was just becoming unacceptable for manufacturers to pour chlorinated solvents down the drain. Through the years, Jim witnessed the industrial environmental transformation first-hand and the dramatic impact of workplace public awareness on workplace and personal health and safety.
Expanding his work into hazardous waste generated by hospitals and universities, Jim recognized an opportunity in the safe collection, destruction, transportation and disposal of cytotoxic chemotherapy. Jim developed and patented Pharma-Cycle Solution for the safe disposal of human waste excreted by chemotherapy patients. He is a passionate advocate for the protection of caregivers, families and our water supply.
Jim holds a B.S. in Chemistry from the University of Massachusetts, Amherst with a concentration in Synthetic Organic Chemistry. He did additional coursework in the Suffolk University M.B.A. program. Professional affiliations include the American Chemical Society, the American Society of Clinical Oncology and the American Society of Health-System Pharmacists.